Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma.
Cailleteau A, Maingon P, Choquet S, Bourdais R, Antoni D, Lioure B, Hulin C, Batard S, Llagostera C, Guimas V, Touzeau C, Moreau P, Mahé MA, Supiot S. Cailleteau A, et al. Among authors: touzeau c. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):677-685. doi: 10.1016/j.ijrobp.2022.09.069. Epub 2022 Sep 27. Int J Radiat Oncol Biol Phys. 2023. PMID: 36174802 Clinical Trial.
ABT-737 is highly effective against molecular subgroups of multiple myeloma.
Bodet L, Gomez-Bougie P, Touzeau C, Dousset C, Descamps G, Maïga S, Avet-Loiseau H, Bataille R, Moreau P, Le Gouill S, Pellat-Deceunynck C, Amiot M. Bodet L, et al. Among authors: touzeau c. Blood. 2011 Oct 6;118(14):3901-10. doi: 10.1182/blood-2010-11-317438. Epub 2011 Aug 11. Blood. 2011. PMID: 21835956 Free article.
Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma.
Lemieux E, Hulin C, Caillot D, Tardy S, Dorvaux V, Michel J, Gastinne T, Rossi C, Legouge C, Touzeau C, Planche L, Loirat M, Lafon I, Moreau P. Lemieux E, et al. Among authors: touzeau c. Biol Blood Marrow Transplant. 2013 Mar;19(3):445-9. doi: 10.1016/j.bbmt.2012.11.013. Epub 2012 Nov 24. Biol Blood Marrow Transplant. 2013. PMID: 23186983 Free article.
Cereblon expression in multiple myeloma: not ready for prime time.
Lodé L, Amiot M, Maiga S, Touzeau C, Menard A, Magrangeas F, Minvielle S, Pellat-Deceunynck C, Bene MC, Moreau P. Lodé L, et al. Among authors: touzeau c. Br J Haematol. 2013 Oct;163(2):282-4. doi: 10.1111/bjh.12478. Epub 2013 Jul 17. Br J Haematol. 2013. PMID: 23862718 Free article. No abstract available.
Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.
Lok A, Mocquard J, Bourcier J, Redelsperger L, Bonnet A, Chauvin C, Thomaré P, Mahé B, Touzeau C, Moreau P. Lok A, et al. Among authors: touzeau c. Haematologica. 2014 Mar;99(3):e33-4. doi: 10.3324/haematol.2013.100396. Epub 2014 Feb 14. Haematologica. 2014. PMID: 24532044 Free PMC article. No abstract available.
Elotuzumab for the treatment of multiple myeloma.
Moreau P, Touzeau C. Moreau P, et al. Among authors: touzeau c. Future Oncol. 2014 May;10(6):949-56. doi: 10.2217/fon.14.56. Future Oncol. 2014. PMID: 24941981 Review.
New data on subcutaneous bortezomib.
Moreau P, Touzeau C. Moreau P, et al. Among authors: touzeau c. Acta Haematol. 2015;133(1):26-8. doi: 10.1159/000362639. Epub 2014 Jul 1. Acta Haematol. 2015. PMID: 24993571 No abstract available.
183 results